Your browser doesn't support javascript.
loading
Scientific and Regulatory Policy Committee Points to Consider*: Review of Scientific and Regulatory Policy Committee Points to Consider: Review of Current Practices for Ultrastructural Pathology Evaluations in Support of Nonclinical Toxicology Studies.
Keirstead, Natalie D; Janovitz, Evan B; Meehan, James T; LeRoy, Bruce E; Megill, John R; Peterson, Richard A; Masson, Regis G; Marxfeld, Heike A.
Affiliation
  • Keirstead ND; 1 Merck & Co, Inc, West Point, PA, USA.
  • Janovitz EB; 2 Bristol-Myers Squibb, Princeton, NJ, USA.
  • Meehan JT; 3 ConsultantMLN ToxPath, LLC, Chazy, NY, USA.
  • LeRoy BE; 4 AbbVie, North Chicago, IL, USA.
  • Megill JR; 2 Bristol-Myers Squibb, Princeton, NJ, USA.
  • Peterson RA; 4 AbbVie, North Chicago, IL, USA.
  • Masson RG; 5 Covance Laboratory SAS, Porcheville, France.
  • Marxfeld HA; 6 BASF SE, Ludwigshafen, Germany.
Toxicol Pathol ; 47(4): 461-468, 2019 06.
Article in En | MEDLINE | ID: mdl-31018785
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pathology, Clinical / Toxicology / Microscopy, Electron, Transmission Type of study: Guideline / Prognostic_studies / Risk_factors_studies Country/Region as subject: America do norte Language: En Journal: Toxicol Pathol Year: 2019 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pathology, Clinical / Toxicology / Microscopy, Electron, Transmission Type of study: Guideline / Prognostic_studies / Risk_factors_studies Country/Region as subject: America do norte Language: En Journal: Toxicol Pathol Year: 2019 Type: Article Affiliation country: United States